↓ Skip to main content

Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

Overview of attention for article published in BMC Psychiatry, December 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
Published in
BMC Psychiatry, December 2011
DOI 10.1186/1471-244x-11-197
Pubmed ID
Authors

Marianne Ulcickas Yood, Gerald N DeLorenze, Charles P Quesenberry, Susan A Oliveria, Ai-Lin Tsai, Edward Kim, Mark J Cziraky, Robert D McQuade, John W Newcomer, Gilbert J L'Italien

Abstract

The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by dose.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Spain 1 1%
Netherlands 1 1%
Unknown 67 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Researcher 12 17%
Student > Ph. D. Student 8 11%
Student > Postgraduate 7 10%
Other 6 8%
Other 14 20%
Unknown 11 15%
Readers by discipline Count As %
Medicine and Dentistry 31 44%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Psychology 6 8%
Agricultural and Biological Sciences 3 4%
Neuroscience 2 3%
Other 6 8%
Unknown 17 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2011.
All research outputs
#13,358,186
of 22,659,164 outputs
Outputs from BMC Psychiatry
#2,774
of 4,630 outputs
Outputs of similar age
#147,175
of 242,419 outputs
Outputs of similar age from BMC Psychiatry
#20
of 33 outputs
Altmetric has tracked 22,659,164 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,630 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,419 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.